全文获取类型
收费全文 | 12369篇 |
免费 | 853篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 168篇 |
儿科学 | 423篇 |
妇产科学 | 494篇 |
基础医学 | 1528篇 |
口腔科学 | 189篇 |
临床医学 | 2056篇 |
内科学 | 2242篇 |
皮肤病学 | 110篇 |
神经病学 | 1018篇 |
特种医学 | 275篇 |
外国民族医学 | 1篇 |
外科学 | 1056篇 |
综合类 | 156篇 |
一般理论 | 19篇 |
预防医学 | 1879篇 |
眼科学 | 122篇 |
药学 | 705篇 |
中国医学 | 3篇 |
肿瘤学 | 788篇 |
出版年
2023年 | 85篇 |
2022年 | 123篇 |
2021年 | 248篇 |
2020年 | 187篇 |
2019年 | 287篇 |
2018年 | 328篇 |
2017年 | 234篇 |
2016年 | 254篇 |
2015年 | 270篇 |
2014年 | 389篇 |
2013年 | 575篇 |
2012年 | 869篇 |
2011年 | 824篇 |
2010年 | 454篇 |
2009年 | 465篇 |
2008年 | 754篇 |
2007年 | 826篇 |
2006年 | 796篇 |
2005年 | 797篇 |
2004年 | 736篇 |
2003年 | 747篇 |
2002年 | 676篇 |
2001年 | 134篇 |
2000年 | 118篇 |
1999年 | 140篇 |
1998年 | 149篇 |
1997年 | 137篇 |
1996年 | 133篇 |
1995年 | 85篇 |
1994年 | 81篇 |
1993年 | 85篇 |
1992年 | 84篇 |
1991年 | 71篇 |
1990年 | 78篇 |
1989年 | 94篇 |
1988年 | 62篇 |
1987年 | 77篇 |
1986年 | 58篇 |
1985年 | 54篇 |
1984年 | 61篇 |
1983年 | 49篇 |
1982年 | 71篇 |
1981年 | 49篇 |
1980年 | 49篇 |
1979年 | 43篇 |
1978年 | 42篇 |
1977年 | 38篇 |
1976年 | 33篇 |
1974年 | 32篇 |
1972年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
J J Lynch A C Uprichard J W Frye E M Driscoll J M Kitzen B R Lucchesi 《Journal of cardiovascular pharmacology》1989,14(4):585-597
The effects of milrinone and pimobendan upon the initiation of programmed ventricular stimulation-induced ventricular tachycardia (VT) and the incidence of lethal ischemic ventricular arrhythmias were assessed in conscious dogs with recent anterior myocardial infarctions. Based upon the results of previous studies, the animals which were entered into this investigation were nonresponsive to baseline programmed stimulation and, therefore, considered to be at "low risk" toward the development of subsequent lethal ischemic arrhythmias. Milrinone (200 micrograms/kg/h continuous i.v. infusion) and pimobendan (300 micrograms/kg i.v.) were administered in dosing regimens shown to produce equivalent and sustained increases in left ventricular (LV) + dP/dt. At the time of repeat electrophysiologic testing, 9 of 9 pimobendan-, 9 of 10 milrinone-, and 12 of 12 concurrent vehicle-treated animals remained nonresponsive to programmed ventricular stimulation. Compared to a total control population of 39 "low risk" postinfarction dogs; however, both milrinone and pimobendan administration increased the incidence of sudden ventricular fibrillation occurring in response to the development of acute posterolateral ischemia (milrinone 4 of 10 [40%] and pimobendan 4 of 10 [40%] versus "low risk" control population 4 of 39 [10.3%]; p = 0.038). The incidence of ischemic mortality at 24 h after the development of posterolateral myocardial ischemia was increased in the milrinone-treated group (6 of 10 [60%]) compared to the "low risk" control population (6 of 39 [15.2%]; p = 0.007), whereas the incidence of 24-h ischemic mortality in the pimobendan-treated group (4 of 10 [40%]) was only of borderline statistical significance when compared to that of the "low risk" control population (p = 0.083). Milrinone, but not pimobendan, delayed the onset of acute posterolateral myocardial ischemia in the postinfarction dogs. The predominant electrophysiologic effects of both milrinone and pimobendan were decreases in ventricular refractoriness in both non-infarct (NZ) and in infarct zones (IZ), as well as reductions in electrocardiographic QTc or QT intervals. These findings suggest that with both positive inotropic agents, including milrinone which may possess protective antithrombotic action, sudden death may be increased via a reduction in ventricular refractoriness in the ischemically injured heart. The enhanced susceptibility toward the development of ischemic ventricular arrhythmias in the presence of the inotropic interventions is not predicted by programmed ventricular stimulation testing prior to the ischemic event. 相似文献
52.
53.
Michael A Tangrea Rodrigo F Chuaqui John W Gillespie Mamoun Ahram Gallya Gannot Benjamin S Wallis Carolyn J M Best W Marston Linehan Lance A Liotta Thomas J Pohida Robert F Bonner Michael R Emmert-Buck 《Diagnostic molecular pathology》2004,13(4):207-212
Tissue microdissection is an important method for the study of disease states. However, it is difficult to perform high-throughput molecular analysis with current techniques. We describe here a prototype version of a novel technique (expression microdissection) that allows for the procurement of desired cells via molecular targeting. Expression microdissection (xMD) offers significant advantages over available methods, including an increase in dissection speed of several orders of magnitude. xMD may become a valuable tool for investigators studying cancer or other disease states in patient specimens and animal models. 相似文献
54.
Chinese hamster cells deficient in ornithine decarboxylase activity: Reversion by gene amplification and by azacytidine treatment 总被引:11,自引:0,他引:11
A group of Chinese hamster ovary (CHO) cell mutants deficient in ornithine decarboxylase (ODC) activity are described and compared to the prototype mutant reported previously (21). Although all mutants belong to the same complementation group, they can be divided into two classes: those with some residual enzyme activity and those with no activity. All mutants are putrescine auxotrophs, but they differ in their ability to utilize the enzyme's substrate, ornithine, a property which correlates with the amount of residual enzyme activity. The mutants also differ in their frequency of reversion to prototrophy. The leaky mutants revert at a high rate by overproducing a partially defective enzyme by a gene amplification mechanism similar to that leading to the ornithine analog-resistant mutants which have elevated enzyme levels. Spontaneous reversion in the null mutants is rare. However, one null mutant, which was induced with ethyl methane sulfonate and which makes ODC mRNA but no active enzyme, is nevertheless revertible with 5-azacytidine. We conclude that CHO cells are at least diploid at the ODC locus, but that only one allele is active. Further studies suggest the possibility that ethyl methane sulfonate is not just a classical mutagen but may also induce gene inactivations that are revertible by 5-azacytidine. 相似文献
55.
56.
Malignant mesothelioma. A cluster in a native American pueblo 总被引:1,自引:0,他引:1
R J Driscoll W J Mulligan D Schultz A Candelaria 《The New England journal of medicine》1988,318(22):1437-1438
57.
Nathaniel H. Robin Beatrice Sellinger Donna McDonald-McGinn Elaine H. Zackai Beverly S. Emanuel Deborah A. Driscoll 《American journal of medical genetics. Part A》1995,56(1):94-96
Deletions of 22qll cause DiGeorge sequence (DGS), velo-cardio-facial syndrome (VCFS), conotruncal anomaly face syndrome, and some isolated conotruncal heart anomalies. Demonstration of a 22qll deletion in a patient with manifestations of DGS and Noonan syndrome (NS) has raised the question of whether NS is another of the chromosome 22 microdeletion syndromes. This prompted us to evaluate a cohort of patients with NS for evidence of 22qll deletions. Five of 6 NS propositi studied in our laboratory with marker N25 (D22S75) did not have a 22qll deletion. A 2-month-old infant with several findings suggestive of NS did have a 22qll deletion, suggesting that a small number of 22qll deletion propositi may present with a NS-like picture. However, most cases of NS must have another cause. © 1995 Wiley-Liss, Inc. 相似文献
58.
Yvonne Myal Carolyn Gregory Hui Wang John L. Hamerton Robert P. C. Shiu 《Somatic Cell and Molecular Genetics》1989,15(3):265-270
The hormonally responsive prolactin-inducible protein (PIP), gene is expressed in benign and malignant breast tumor tissues and in such normal exocrine organs as sweat, salivary, and lacrimal glands. In this communication we report the regional chromosome localization of the PIPgene locus to chromosome 7 by Southern hybridization to DNA from human-hamster somatic cell hybrids, and to 7q32–36 by in situ hybridization. 相似文献
59.
60.
Roberto T. Zori Brian A. Gray Angela Bent-Williams Daniel J. Driscoll Charles A. Williams Joleen L. Zackowski 《American journal of medical genetics. Part A》1993,46(4):379-383
We report on an infant with preaxial acrofacial dysostosis (Nager syndrome) who was diagnosed prenatally as having an apparently balanced X/autosome translocation [46,X,t(X;9)(p22.1;q32)mat] inherited from a previously diagnosed mosaic translocation carrier mother [46,XX/46,X,t(X;9)(p22.1;q32)]. Replication studies on amniocytes showed the normal X chromosome to be late replicating while the same studies repeated on the infant's lymphocytes showed the translocated X chromosome to be late replicating in most cells. Late replication studies of the mother's lymphocytes demonstrated that the normal X chromosome was late replicating in most cells. The presence of Nager syndrome in this infant may be the result of critical break-points and/or position effects on chromosome 9, inducing expression of a gene responsible for the syndrome. © 1993 Wiley-Liss, Inc. 相似文献